{Reference Type}: Journal Article
{Title}: Benralizumab reduces blood basophil percentage and activation in vitro without eliciting degranulation.
{Author}: Gil-Martínez M;Rodrigo-Muñoz JM;Lorente-Sorolla C;de Castro ZG;Mínguez P;Cañas JA;Valverde-Monge M;Bernaola J;Pinillos-Robles EJ;Betancor D;Fernández-Nieto M;Sastre J;Rodríguez-Nieto MJ;Del Pozo V;
{Journal}: Allergy
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 6
{Factor}: 14.71
{DOI}: 10.1111/all.16190